Key result
C-ERAS pathway linked to ~2-day shorter hospital stay after CABG vs routine care.
Why the study?
Enhanced Recovery After Surgery (ERAS) aims to improve outcomes after surgery, but its application and impact in elective coronary artery bypass grafting (CABG) required evaluation.
Does a Cardiac ERAS (C-ERAS) pathway reduce length of stay and costs in patients undergoing elective CABG?
Cohort (n=213)
No
Does a Cardiac ERAS (C-ERAS) pathway reduce length of stay and costs in patients undergoing elective CABG?
Mean Difference: 2.36 (95% CI 1.01–3.7)
Absolute Event Rate: 7% vs 8%
p-value: p=<0.01
Implementation of a Cardiac ERAS pathway for elective CABG significantly reduces hospital length of stay and costs without increasing complications or readmissions.
C-ERAS was associated with shorter LOS after CABG; leaves open efficacy and safety in randomized trials.
Enhanced Recovery After Surgery (ERAS) incorporates multi-modal interventions that synergistically improve patient outcome.Its goals include improving patients functionally pre-operatively, reducing the stress of surgery intra-operatively to facilitate early return to daily activities.We conducted a pilot study at our unit recruiting patients undergoing elective coronary artery bypass grafting (CABG) into the Cardiac ERAS (C-ERAS) pilot and compared them with the patients undergoing CABG meeting the ERAS criteria but who not included the C-ERAS pilot (Control).Materials and Methods: 122 C-ERAS patients were compared to 91 control patients who underwent CABG only from the period of July 2015 to September 2016.All C-ERAS patients received pre-operative counselling by a dedicated ERAS Practitioner to manage expectations of the patient journey, health promotion and pre-operative optimisation advice.Emphasis was made on educating the patient on daily goals for recovery and patients were followed up daily by the ERAS practitioner post-operatively.Results: There were 122 patients in the C-ERAS group and 91 patients in the control group.The mean age was 63.6±9.9 years.181(85%) of the patients were males.After adjusting for the abovementioned confounders, C-ERAS patients had a shorter length of stay that was statistically significant.(2.36 days shorter (95% CI; 1.01-3.7 days; p<0.01).The difference in mean bed day costs was £1153.70 (95% CI, £553.70-£1753.7;p<0.01) less in the C-ERAS cohort.Conclusion: This study highlighted that C-ERAS is a safe and feasible pathway to reduce in-hospital stay with no difference in complications and readmission rates compared to routine management of patients.There was also a significant cost saving with the C-ERAS pathway mimicking the results in enhanced recovery programmes in the other surgical specialities.
No takes yet. Share an insight, caveat, or question.
Singh et al. (2020) conducted a cohort in Coronary artery disease requiring elective CABG (n=213). Cardiac Enhanced Recovery After Surgery (C-ERAS) pathway vs. Routine management (Control) was evaluated on Length of hospital stay (MD 2.36 days shorter, 95% CI 1.01-3.7, p=<0.01). The Cardiac Enhanced Recovery After Surgery (C-ERAS) pathway significantly reduced hospital length of stay by an adjusted mean of 2.36 days compared to routine management in patients undergoing CABG.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: